Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Toro

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
AIDS Research and Human Retroviruses|July 29, 2003
Transmission of HIV type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donorCarlos Toro, Berta Rodés, Félix Colino, et al.
Journal of Substance Abuse Treatment|September 18, 2007
Hepatitis B vaccination: an unmet challenge in the era of harm reduction programsFernando Vallejo, Carlos Toro, Luis de la Fuente, et al.
Antiviral Therapy|April 9, 2008
Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?Julie Sheldon, Belén Ramos, Carlos Toro, et al.
Journal of Epidemiology and Community Health|May 16, 2006
Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmesLuis de la Fuente, María José Bravo, Carlos Toro, et al.
Journal of Virology|September 14, 2012
Long-term nonprogressor and elite controller patients who control viremia have a higher percentage of methylation in their HIV-1 proviral promoters than aviremic patients receiving highly active antiretroviral therapyJuan Antonio Palacios, Teresa Pérez-Piñar, Carlos Toro, et al.
AIDS Research and Human Retroviruses|November 6, 2015
Short Communication: p21/CDKN1A Expression Shows Broad Interindividual Diversity in a Subset of HIV-1 Elite ControllersAlicia de Pablo, Roberta Bogoi, Irene Bejarano, et al.
Materials Science & Engineering. C, Materials for Biological Applications|April 4, 2021
Structure-function assessment of 3D-printed porous scaffolds by a low-cost/open source fused filament fabrication printerRaúl Vallejos Baier, José I Contreras Raggio, Carlos Toro Arancibia, et al.
Neurotrauma Reports|January 12, 2022
Administration of High-Dose Methylprednisolone Worsens Bone Loss after Acute Spinal Cord Injury in RatsYuanzhen Peng, Wei Zhao, Yizhong Hu, et al.
IEEE Computer Graphics and Applications|March 26, 2015
Visual computing as a key enabling technology for Industrie 4.0 and Industrial InternetJorge Posada, Carlos Toro, Iñigo Barandiaran, et al.
AIDS (London, England)|May 29, 2004
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infectionBerta Rodés, Carlos Toro, Ellen Paxinos, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
AIDS Research and Human Retroviruses|July 29, 2003
Transmission of HIV type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donorCarlos Toro, Berta Rodés, Félix Colino, et al.
Journal of Substance Abuse Treatment|September 18, 2007
Hepatitis B vaccination: an unmet challenge in the era of harm reduction programsFernando Vallejo, Carlos Toro, Luis de la Fuente, et al.
Antiviral Therapy|April 9, 2008
Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?Julie Sheldon, Belén Ramos, Carlos Toro, et al.
Journal of Epidemiology and Community Health|May 16, 2006
Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmesLuis de la Fuente, María José Bravo, Carlos Toro, et al.
Journal of Virology|September 14, 2012
Long-term nonprogressor and elite controller patients who control viremia have a higher percentage of methylation in their HIV-1 proviral promoters than aviremic patients receiving highly active antiretroviral therapyJuan Antonio Palacios, Teresa Pérez-Piñar, Carlos Toro, et al.
AIDS Research and Human Retroviruses|November 6, 2015
Short Communication: p21/CDKN1A Expression Shows Broad Interindividual Diversity in a Subset of HIV-1 Elite ControllersAlicia de Pablo, Roberta Bogoi, Irene Bejarano, et al.
Materials Science & Engineering. C, Materials for Biological Applications|April 4, 2021
Structure-function assessment of 3D-printed porous scaffolds by a low-cost/open source fused filament fabrication printerRaúl Vallejos Baier, José I Contreras Raggio, Carlos Toro Arancibia, et al.
Neurotrauma Reports|January 12, 2022
Administration of High-Dose Methylprednisolone Worsens Bone Loss after Acute Spinal Cord Injury in RatsYuanzhen Peng, Wei Zhao, Yizhong Hu, et al.
IEEE Computer Graphics and Applications|March 26, 2015
Visual computing as a key enabling technology for Industrie 4.0 and Industrial InternetJorge Posada, Carlos Toro, Iñigo Barandiaran, et al.
AIDS (London, England)|May 29, 2004
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infectionBerta Rodés, Carlos Toro, Ellen Paxinos, et al.
Pageof 14